Mental Health Market to Worth USD 526.21 Billion by 2030 | Skyquest Technology

In This Article:

SkyQuest Technology Consulting Pvt. Ltd.
SkyQuest Technology Consulting Pvt. Ltd.

Mental health market is segmented on the basis of age group, services. Based on age group, the market is classified into pediatric, adult, and geriatric. In terms of services, the market is segmented into emergency mental health services, outpatient counseling, home-based treatment services, inpatient hospital treatment services, and other services- Industry forecast 2023-2030

Westford, USA, Jan. 10, 2024 (GLOBE NEWSWIRE) -- According to SkyQuest, the global mental health market encompasses many products and services to address the prevention, treatment, and management of mental health disorders. This multi-layered market incorporates pharmaceuticals designed to alleviate symptoms and improve the well-being of individuals grappling with mental health issues.

Browse in-depth TOC on the "Mental Health Market"     

  • Pages - 157

  • Tables -  65

  • Figures – 75

The primary driving force behind the global mental health market is the escalating prevalence of mental health disorders globally. There is a growing awareness and acceptance of these issues, further fueling the market's expansion as societies become more attuned to the significance of mental health.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/mental-health-market

Report Scope & Segmentation:                          

Attributes

Details

Market Size in 2022

USD 399.61 Billion

2030 Value Projection

USD 526.21 Billion

CAGR

3.5%

Forecast Period

2023-2030

Segments Covered

  • Age Group

  • Services

 

Regions Covered

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

Prominent Players in the Mental Health Market

  • Pfizer Inc.

  • Johnson & Johnson

  • Eli Lilly and Company

  • Bristol-Myers Squibb

  • GlaxoSmithKline

  • AstraZeneca

  • Allergan plc

  • Merck & Co., Inc.

  • Takeda Pharmaceutical Company Limited

  • Otsuka Holdings Co., Ltd.

  • Novartis International AG

  • Sanofi S.A.

  • Lundbeck A/S

  • Teva Pharmaceutical Industries Ltd.

  • Mylan N.V.

  • AbbVie Inc.

  • Boehringer Ingelheim International GmbH

  • H. Lundbeck A/S

  • Sun Pharmaceutical Industries Ltd.

  • Alkermes plc

Pediatric Segment is Expected to Grow in the Market Due to a Wide Spectrum of Assessments

Pediatric age group encompasses children and adolescents up to 18 years of age, and within this critical developmental stage, pediatric mental health services play a pivotal role. These services encompass a broad spectrum of assessments and treatments to address various mental health conditions that can impact young individuals in the mental health market.

The markets in North America exert significant dominance over the global mental health market, and within the region, the United States stands out as the largest market. Several factors contribute to this preeminence.